Copyright © 2006, European Society of Cardiology
Estrogen protection, oxidized LDL, endothelial dysfunction and vasorelaxation in cardiovascular disease: New insights into a complex issue
Indiana University School of Medicine, Department of Cellular and Integrative Physiology, 635 Barnhill Drive, Indianapolis, Indiana 46202-5120, United States
* Tel.: +1 317 274 9765; fax: +1 317 274 3318. Email address: spacker1@iupui.edu
Received 5 November 2006; accepted 9 November 2006
| The first 10% of the full text of this article appears below. |
See article by Monsalve et al. [14] (pages 66–72) in this issue.
Pre-menopausal women have a lower risk of developing hypertension than men or post-menopausal women [1]. Estrogens may prevent or delay the onset of hypertension in pre-menopausal women. Similarly, animal models such as the spontaneously hypertensive rat (SHR) exhibit sexual dichotomy in development of essential hypertension, and estrogen reduces blood pressure in hypertensive female rats [2,3]. Such animal models are useful in the study of the protective effects of estrogen in the development